オプトジェネティクス市場：製品タイプ、用途、技術、地域別、2026年～2032年

オプトジェネティクス市場の評価、2026年～2032年

オプトジェネティクス市場は、神経科学研究と治療用途における革命的な可能性により、人気が高まっています。この新しい技術は、遺伝子工学と光学を利用して、光を用いて特定の細胞の活動を制御するもので、生物学的システムの調査と変更において比類のない精度と特異性を提供します。市場規模は、2024年に500億7,000万米ドルを超え、2032年には1,794億6,000万米ドルに達します。

オプトジェネティクスの理解が深まり、その応用が広がるにつれて、技術的ブレークスルー、研究資金の増加、学界と産業界のコラボレーションによって市場はさらに拡大すると見られています。費用対効果が高く効率的なオプトジェネティクスに対する需要の高まりが、2026～2032年のCAGR 17.30%での市場成長を可能にしています。

オプトジェネティクス市場定義/概要

オプトジェネティクスは、光感受性イオンチャネルを発現するように遺伝子操作された生体組織の細胞（通常は神経細胞）を光で制御する技術です。特定の波長の光は、チャネル・ロドプシンなどのこれらのチャネルを活性化またはブロックすることができ、細胞の活動を正確に制御することができます。このアプローチにより、研究者は神経細胞ネットワークをリアルタイムで見たり変化させたりすることができ、脳の活動がどのように行動に影響を及ぼすかについて詳細な洞察を得ることができます。オプトジェネティクスは、自由に動く動物の個々の細胞タイプを操作することを可能にし、脳機能、記憶、神経疾患の理解に進歩をもたらし、神経科学を一変させました。

オプトジェネティクスは単なる基礎研究にとどまらず、治療への応用も期待されています。神経科学では、パーキンソン病、てんかん、うつ病などの疾患に関連する脳回路のマッピングや、動物モデルにおける視力の回復に用いられています。オプトジェネティクスは、機能不全に陥った脳回路を正確にターゲットにすることで、神経疾患や精神疾患に対するより良い治療法を生み出す可能性を秘めています。オプトジェネティクスと遺伝子治療の進歩により、人間においても非侵襲的で高度に的を絞った治療が可能になり、失明や慢性疼痛、さらには記憶の拡張や回復の治療につながる可能性があります。

神経疾患の有病率の増加は、オプトジェネティクス市場をどのように牽引するか？

神経疾患の有病率の上昇は、オプトジェネティクス市場を非常に押し上げています。神経疾患は世界第2位の死亡原因であり、多大な障害調整生存年数（DALYs）を占めているため、より良い治療法や研究に対する需要が高まっています。オプトジェネティクスは、脳の活動を精密に制御できる最先端のアプローチであり、こうした疾患の理解と治療に役立つ可能性を秘めています。効果的な治療法と神経疾患のより深い理解に対する需要の高まりが、光遺伝学分野への投資と技術革新を後押ししています。

神経科学研究における資金提供の増加が、オプトジェネティクス市場を前進させています。NIHの神経科学研究予算83億米ドル（2023会計年度）やEUのヒューマン・ブレイン・プロジェクト（Human Brain Project）を通した10億ユーロ超の投資などのイニシアティブによる大規模な資金調達は、研究能力と技術的ブレークスルーをかなり改善します。このような財政支援の拡大は、より複雑な光遺伝学装置や技術の開発を可能にし、技術革新を加速し、様々な神経学研究や治療における光遺伝学の利用を改善し、結果として市場成長を拡大します。

高費用はどのようにオプトジェネティクス市場の成長を妨げるか？

高い費用がオプトジェネティクス市場の拡大を制限すると予測されています。オプトジェネティクスは高度に専門化された学問分野であり、レーザーシステムや遺伝子工学的に設計されたツールなどの高度な機器が必要であり、その開発や維持にはコストがかかります。さらに、研究、臨床試験、科学者や医療専門家の専門的トレーニングにかかる費用も財政的負担に拍車をかけています。そのため、中小企業や研究機関が市場に参入することが難しくなり、技術革新と普及が阻害されます。また、こうしたコストの障害は、病院や研究所へのアクセスを制限し、市場全体の拡大を妨げる可能性もあります。

技術の複雑さは、オプトジェネティクス市場の成長に影響を与えます。オプトジェネティクスには、光感受性タンパク質を発現させるために細胞を遺伝子改変したり、神経細胞活動を正確に制御するために光を利用したりするような複雑な技術が含まれます。これらの技術的問題は、専門的な知識と装置を必要とするため、研究および臨床現場での普及を困難にしています。科学者や医師にとって学習曲線が険しいことと、近代的なインフラの必要性が相まって、産業の拡大を妨げる可能性があります。さらに、複雑さが光遺伝学的研究の実際の医薬品への転換を遅らせ、その拡張性と経済的応用を制限する可能性もあります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 オプトジェネティクス市場：製品タイプ別

• 光機器
• センサー
• アクチュエーター

第5章 オプトジェネティクス市場：用途別

• 循環器科
• 網膜疾患治療
• 神経科学

第6章 オプトジェネティクス市場：技術別

• トランスジェニック動物
• ウイルス伝達
• Cre依存発現

第7章 オプトジェネティクス市場地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Coherent, Inc.
• Scientifica（Judges Scientific）
• Noldus Information Technology
• Thorlabs, Inc.
• GenSight Biologics
• Addgene
• Elliot Scientific Ltd.
• Bruker Corporation
• Shanghai Laser & Optics Century Co., Ltd.（SLOC）
• The Jackson Laboratory

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Optogenetics Market Valuation - 2026-2032

The optogenetics market is growing in popularity owing to its revolutionary potential in neuroscience research and therapeutic applications. This novel technology uses genetic engineering and optics to regulate the activity of particular cells using light, providing unparalleled precision and specificity in investigating and altering biological systems. The market size surpass USD 50.07 Billion valued in 2024 to reach a valuation of around USD 179.46 Billion by 2032.

As the comprehension of optogenetics grows and its applications broaden, the market is likely to expand further, fueled by technological breakthroughs, increasing research funding, and collaborations between academia and industry. The rising demand for cost-effective and efficient optogenetics is enabling the market grow at a CAGR of 17.30% from 2026 to 2032.

Optogenetics Market: Definition/ Overview

Optogenetics is a technique that uses light to control cells in living tissue, usually neurons, that have been genetically engineered to express light-sensitive ion channels. Specific wavelengths of light can activate or block these channels, such as channel rhodopsin, allowing for precise control over cell activity. This approach allows researchers to view and change neuronal networks in real-time, providing detailed insights into how brain activity influences behavior. Optogenetics has transformed neuroscience by allowing scientists to manipulate individual cell types in freely moving animals, resulting in advancements in understanding brain function, memory, and neurological illnesses.

Optogenetics is used for more than just basic research; it has potential therapeutic applications. In neuroscience, it has been used to map brain circuits associated with disorders including Parkinson's, epilepsy, and depression, as well as to restore vision in animal models. Optogenetics has the potential to produce better treatments for neurological and mental illnesses by precisely targeting malfunctioning brain circuits. Advances in optogenetics and gene therapy may enable non-invasive, highly targeted therapies in humans, potentially leading to cures for blindness, chronic pain, and even memory augmentation or restoration.

How Will the Increasing Prevalence of Neurological Illnesses Drive the Optogenetics Market?

The rising prevalence of neurological illnesses is boosting the optogenetics market extremely. With neurological illnesses ranking as the second biggest cause of mortality worldwide and accounting for significant disability-adjusted life years (DALYs), there is an increasing demand for better therapies and research. Optogenetics, a cutting-edge approach that allows for precise control of brain activity, has the potential to help us understand and cure these disorders. The increasing demand for effective therapeutics and a deeper understanding of neurological illnesses drives investment and innovation in the optogenetics sector.

Increased funding in neuroscience research is propelling the optogenetics market ahead. The large financing from initiatives such as the NIH's $8.3 billion budget for neuroscience research in fiscal year 2023 and the EU's over €1 billion investment through the Human Brain Project considerably improves research capacity and technical breakthroughs. This increasing financial support allows for the development of more complex optogenetic instruments and techniques, accelerates innovation, and improves the use of optogenetics in a variety of neurological studies and therapies, consequently extending market growth.

How Does the High-Cost Hamper the Growth of the Optogenetics Market?

High expenses are anticipated to limit the expansion of the optogenetics market. Optogenetics is a highly specialized discipline that necessitates sophisticated equipment, such as laser systems and genetically designed tools, which can be costly to develop and maintain. Furthermore, the costs of research, clinical trials, and specialized training for scientists and medical professionals add to the financial burden. This makes it more difficult for smaller enterprises or research institutes to enter the market, thereby impeding innovation and uptake. These cost obstacles may also limit its accessibility to hospitals and research labs, hurting overall market expansion.

Technical complexity will have an impact on the growth of the optogenetics market. Optogenetics involves complex techniques such as genetically modifying cells to express light-sensitive proteins and using light to precisely control neuronal activity. These technical problems necessitate specialized knowledge and equipment, making widespread adoption challenging in research and clinical settings. The steep learning curve for scientists and physicians, combined with the need for modern infrastructure, may impede industry expansion. Furthermore, complexity can cause delays in the translation of optogenetic research into actual medicines, limiting its scalability and economic application.

Category-Wise Acumens

Will the Ability to Regulate Neuronal Activity Propel the Actuators Segment's Growth for the Optogenetics Market?

The capacity to control neural activity is projected to boost the actuators section of the optogenetics market. This is because optogenetics uses light to precisely control neurons, making it an effective tool for understanding and affecting brain networks. Actuators in optogenetics allow for real-time regulation of neural activity, which is critical for applications in neuroscience research, neurological disease therapy, and brain-machine interfaces. As research in these areas continues, the requirement for sophisticated actuator technologies capable of controlling neurons with great accuracy is expected to fuel market expansion.

The ongoing discovery of new actuator proteins with superior properties is expected to promote the expansion of the actuators segment in the optogenetics market. Enhanced actuator proteins can provide better precision, efficiency, and versatility in directing biological functions with light, which encourages their use in research and therapeutic settings. These developments lead to better experimental results and potential therapeutic solutions, making optogenetics more appealing to researchers and physicians. As these proteins improve, their range of applications expands, increasing overall market demand

Will the Capacity to Provide Stable and Long-Term Expression of Optogenetic Proteins Promote the Growth of the Transgenic Animals Segment in the Optogenetics Market?

The ability to offer consistent and long-term expression of optogenetic proteins will most likely drive the expansion of the transgenic animal segment in the optogenetics market. Stable expression guarantees that optogenetic proteins continue to operate over time, which is critical for long-term investigations and experiments in transgenic animals. These animal models are more valuable to researchers studying chronic illnesses or the long-term impacts of optogenetic therapies because of their reliability. As a result, demand for such transgenic models rises, propelling growth in this market segment.

The power to control expression will drive the expansion of the transgenic animal segment in the optogenetics market. Controlled expression enables precise regulation of gene activity in specific cells or tissues of transgenic animals, resulting in more accurate studies of gene function and the impact of optogenetic interventions. This precision increases the usefulness of transgenic models in research and drug development, resulting in greater utilization in the optogenetics sector. As researchers look for more precise and dependable models to study complicated biological processes and develop new treatments, the need for transgenic animals with regulated expression capabilities will increase.

Country/Region-wise Acumens

Will the Strong Research Infrastructure Lead the North American Region for the Optogenetics Market?

The region is home to world-class research institutions and universities that are leading advances in neuroscience and optogenetics. North America has the largest share of the market globally, thanks to significant funding from agencies such as the National Institutes of Health (NIH), which funded around $96 million in optogenetics-related research in 2021-a 15% increase over the previous year. This research support, combined with the region's emphasis on discovering treatments for neurological disorders such as Alzheimer's and Parkinson's, which afflict 6.7 million Americans aged 65 and up, is boosting demand for advanced optogenetic techniques. As these diseases continue to develop, with Alzheimer's cases expected to reach 13.8 million by 2060, the region's robust research infrastructure will play an important role in driving market expansion.

Significant investments are fueling the North American optogenetics market's expansion. Public financing, such as the $115 million granted by the NIH in 2022, a 20% increase over the previous year, and private investments totaling $450 million by 2023, are speeding progress in the field. These investments are driving innovation, extending neuroscience applications, and addressing the growing prevalence of neurological illnesses such as Alzheimer's and Parkinson's. The FDA's regulatory support for optogenetics-based therapeutics promotes market growth by enabling the translation of research into clinical applications.

Will the Rapid Economic Development Expand the Asian Pacific Region for the Optogenetics Market?

The Asia-Pacific region is experiencing the fastest growth in the optogenetics market. Rapid economic development is boosting the Asia Pacific optogenetics market. This economic expansion has resulted in greater spending in scientific research and healthcare, considerably expanding the optogenetics sector. As the region's economies grow, countries such as China and Japan devote significant resources to neuroscience research, including optogenetics. The increased frequency of neurological illnesses, including a projected increase in dementia cases from 20.1 million in 2021 to 61.4 million by 2050, is pushing the need for novel treatments. This combination of financial investment and increased healthcare demand is hastening the development and deployment of optogenetics technology in the region.

Government support is propelling the Asia Pacific optogenetics market to new heights of growth and placing it as the global leader. This support is demonstrated by significant expenditures in brain science, including China's $1 billion, Japan's $40 million per year for the Brain/MINDS initiative, and South Korea's $37 million. These investments are crucial due to addressing the increasing frequency of neurological illnesses such as dementia and Parkinson's disease, which is boosting demand for new therapies. The increase in government-funded optogenetics programs in China, which has grown by 25% per year since 2018, demonstrates the region's dedication to improving this sector, which will drive additional market expansion.

Competitive Landscape

The optogenetics market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the optogenetics market include:

• Coherent, Inc.,
• Scientifica (Judges Scientific),
• Noldus Information Technology,
• Thorlabs Inc.
• GenSight Biologics
• Addgene, Elliot Scientific Ltd.
• Bruker Corporation
• Shanghai Laser & Optics Century Co.
• (SLOC)
• The Jackson Laboratory

Latest Developments

• In June 2022, Bruker Corporation introduced the NeuraLight 3D Ultra module to assist advanced neuroscience and optogenetics research applications on its Ultima multiphoton microscopes.
• In February 2023, GenSight Biologics announced the 1-year safety and efficacy results from the PIONEER phase I/II clinical study of GS030, an optogenetic therapy option for retinitis pigmentosa.

Optogenetics Market, By Category

• Product Type:
• Light Instruments
• Sensors
• Actuators
• Application:
• Cardiology
• Retinal Disease Treatment
• Neuroscience
• Technique:
• Transgenic Animals
• Viral Transduction
• Cre-Dependent Expression
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Optogenetics Market, By Product Type

• Light Instruments
• Sensors
• Actuators

5. Optogenetics Market, By Application

• Cardiology
• Retinal Disease Treatment
• Neuroscience

6. Optogenetics Market, By Technique

• Transgenic Animals
• Viral Transduction
• Cre-Dependent Expression

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Coherent, Inc.
• Scientifica (Judges Scientific)
• Noldus Information Technology
• Thorlabs, Inc.
• GenSight Biologics
• Addgene
• Elliot Scientific Ltd.
• Bruker Corporation
• Shanghai Laser & Optics Century Co., Ltd. (SLOC)
• The Jackson Laboratory

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References